Literature DB >> 19020798

Association study to evaluate the serotonin transporter and apolipoprotein E genes in frontotemporal lobar degeneration in Italy.

Diego Albani1, Francesca Prato2, Chiara Fenoglio3, Sara Batelli2, Sabrina Dusi2, Stefania De Mauro2, Letizia Polito2, Carlo Lovati4, Daniela Galimberti3, Claudio Mariani4, Elio Scarpini3, Gianluigi Forloni2.   

Abstract

Frontotemporal lobar degeneration (FTLD) is a progressive neurodegenerative disorder characterized by behavioral and language disturbances. We performed a case-control association study in the Italian population to assess the relevance for FTLD genetic susceptibility of the serotonin (5-HT) transporter gene-linked polymorphic region [rs4795541, alias short (S)/long (L)] an in/del polymorphism of the promoter region of the gene coding for the 5-HT transporter (SLC6A4). This functional polymorphism was reported to influence the SLC6A4 transcription rate, with the S-allele having a two-fold reduced efficiency. We collected 225 independent subjects (74 sporadic FTLD and 151 age-matched healthy controls, CT) that were genotyped for the rs4795541, the SLC6A4 single nucleotide polymorphisms (SNP) rs25531 and rs6354, and the apolipoprotein E (APOE) allelic variants. A significant correlation [P = 0.018, OR (95% CI): 2.1 (1.1-3.9)] between rs4795541 S-allele presence and FTLD susceptibility was found. In summary, the rs4795541 might be important for FTLD susceptibility in the Italian population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020798     DOI: 10.1007/s10038-008-0344-5

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  15 in total

1.  Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method.

Authors:  Y Yang; H P Schmitt
Journal:  Acta Neuropathol       Date:  2001-03       Impact factor: 17.088

2.  The effects of APOE and tau gene variability on risk of frontotemporal dementia.

Authors:  L Bernardi; R G Maletta; C Tomaino; N Smirne; M Di Natale; M Perri; T Longo; R Colao; S A M Curcio; G Puccio; M Mirabelli; T Kawarai; E Rogaeva; P H St George Hyslop; G Passarino; G De Benedictis; A C Bruni
Journal:  Neurobiol Aging       Date:  2006-05       Impact factor: 4.673

Review 3.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

4.  A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders.

Authors:  D A Collier; G Stöber; T Li; A Heils; M Catalano; D Di Bella; M J Arranz; R M Murray; H P Vallada; D Bengel; C R Müller; G W Roberts; E Smeraldi; G Kirov; P Sham; K P Lesch
Journal:  Mol Psychiatry       Date:  1996-12       Impact factor: 15.992

5.  The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants.

Authors:  M Nakamura; S Ueno; A Sano; H Tanabe
Journal:  Mol Psychiatry       Date:  2000-01       Impact factor: 15.992

6.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.

Authors:  G M McKhann; M S Albert; M Grossman; B Miller; D Dickson; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-11

7.  Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis.

Authors:  Patrice Verpillat; Agnès Camuzat; Didier Hannequin; Catherine Thomas-Anterion; Michèle Puel; Serge Belliard; Bruno Dubois; Mira Didic; Lucette Lacomblez; Olivier Moreaud; Véronique Golfier; Dominique Campion; Alexis Brice; Françoise Clerget-Darpoux
Journal:  Eur J Hum Genet       Date:  2002-07       Impact factor: 4.246

8.  Allelic variation of human serotonin transporter gene expression.

Authors:  A Heils; A Teufel; S Petri; G Stöber; P Riederer; D Bengel; K P Lesch
Journal:  J Neurochem       Date:  1996-06       Impact factor: 5.372

9.  A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder.

Authors:  Jens R Wendland; Pablo R Moya; Matthew R Kruse; Renee F Ren-Patterson; Catherine L Jensen; Kiara R Timpano; Dennis L Murphy
Journal:  Hum Mol Genet       Date:  2007-11-30       Impact factor: 6.150

10.  Organization of the human serotonin transporter gene.

Authors:  K P Lesch; U Balling; J Gross; K Strauss; B L Wolozin; D L Murphy; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1994
View more
  5 in total

1.  Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: preliminary findings.

Authors:  Cristina Lorenzi; Alessandra Marcone; Adele Pirovano; Elena Marino; Francesco Cordici; Chiara Cerami; Dario Delmonte; Stefano F Cappa; Placido Bramanti; Enrico Smeraldi
Journal:  Neurol Sci       Date:  2010-09-18       Impact factor: 3.307

2.  A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk.

Authors:  Letizia Polito; Francesca Prato; Serena Rodilossi; Eleonora Ateri; Daniela Galimberti; Elio Scarpini; Francesca Clerici; Claudio Mariani; Gianluigi Forloni; Diego Albani
Journal:  Int J Alzheimers Dis       Date:  2011-06-02

3.  Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.

Authors:  Wen-Hua Su; Zhi-Hong Shi; Shu-Ling Liu; Xiao-Dan Wang; Shuai Liu; Yong Ji
Journal:  Oncotarget       Date:  2017-07-04

4.  The 5-HTTLPR variant in the serotonin transporter gene modifies degeneration of brain regions important for emotion in behavioral variant frontotemporal dementia.

Authors:  Jennifer S Yokoyama; Luke W Bonham; Virginia E Sturm; Babu Adhimoolam; Anna Karydas; Giovanni Coppola; Bruce L Miller; Katherine P Rankin
Journal:  Neuroimage Clin       Date:  2015-08-18       Impact factor: 4.881

Review 5.  Neurotransmitter deficits from frontotemporal lobar degeneration.

Authors:  Alexander G Murley; James B Rowe
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.